TTTSF - TruTrace Technologies Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0300
-0.0040 (-11.76%)
At close: 3:06PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.0340
Open0.0322
BidN/A x N/A
AskN/A x N/A
Day's Range0.0285 - 0.0331
52 Week Range0.0152 - 0.2521
Volume7,838
Avg. Volume61,844
Market Cap2.759M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • TruTrace Technologies and AdvancedCare announce strategic plan to integrate technology platforms
      CNW Group

      TruTrace Technologies and AdvancedCare announce strategic plan to integrate technology platforms

      TORONTO , Oct. 16, 2019 /CNW/ - TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF) ("TruTrace" or "the Company"), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, and AdvancedCare, a leading clinical research, clinical and telemedicine platform used by medical professionals around the world, today announced that the two companies have entered into a letter of intent ("LOI") to begin a strategic working relationship to integrate their technologies to bring innovative solutions to the medical industry. Pursuant to the LOI, AdvancedCare plans to integrate TruTrace's StrainSecure ™ technology within its own platform, with the objective of providing product data directly to medical professionals, patients and researchers to ensure medication has been verified and is safe to consume.

    • TruTrace Technologies and Sigma Analytical to Collaborate on Genetic Testing for Cannabis
      CNW Group

      TruTrace Technologies and Sigma Analytical to Collaborate on Genetic Testing for Cannabis

      TORONTO , Oct. 7, 2019 /CNW/ - TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF) ("TruTrace"), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, and Sigma Analytical Services ("Sigma Analytical"), a provider of comprehensive testing and analytical services for the cannabis industry, today announced that the two companies have entered into a letter of intent ("LOI") to establish a strategic working relationship. Pursuant to the LOI, TruTrace plans to include Sigma Analytical as a genetics verification and testing partner in its blockchain-secured traceability ecosystem, and the parties will explore development and integration opportunities to rapidly expedite and optimize testing processes in the cannabis and hemp industries.

    • TruTrace Technologies Announces First Quarter 2020 Financial and Operating Results
      CNW Group

      TruTrace Technologies Announces First Quarter 2020 Financial and Operating Results

      TORONTO , Sept. 24, 2019 /CNW/ - TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF) ("TruTrace" or the "Company"), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today announced its first quarter financial and operating results for the three months ended July 31, 2019 . "The launch of the Shoppers Drug Mart Pilot Program for medical cannabis verification was a very significant milestone for us in the first quarter," said TruTrace Technologies CEO Robert Galarza . "This has provided us with a unique opportunity to demonstrate the effectiveness of our technology to several of Canada's leading licensed producers and other key industry participants.

    • TruTrace Technologies Closes Second Tranche of Private Placement
      CNW Group

      TruTrace Technologies Closes Second Tranche of Private Placement

      VANCOUVER , Sept. 13, 2019 /CNW/ - TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF) ("TruTrace" or the "Company") today announced that it has closed a second tranche (the "Second Tranche") of a non-brokered private placement financing (the "Financing").  The Second Tranche consisted of 840,950 units (each, a "Unit") of the Company at a price of $0.25 per Unit for gross proceeds of $210,237.50 . Each Unit consists of one common share and one non-transferable common share purchase warrant (each, a "Warrant"). Each Warrant entitles the holder to purchase one additional common share at a price of $0.30 per common share for a period of three (3) years from the closing of the Financing. To date, the Company has raised gross proceeds of $720,237.50 from the first tranche of the Financing and the Second Tranche.  The Company expects to close a third tranche of the Financing in a timely manner.

    • Aphria Inc. joins Shoppers Drug Mart and TruTrace Technologies Pilot Program for Medical Cannabis Verification
      CNW Group

      Aphria Inc. joins Shoppers Drug Mart and TruTrace Technologies Pilot Program for Medical Cannabis Verification

      TORONTO and LEAMINGTON, ON , Sept. 5, 2019 /CNW/ - Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) and TruTrace Technologies Inc. (CSE:TTT) (OTCQB:TTTSF) ("TruTrace") today announced that Aphria has joined Phase 2 of the Shoppers Drug Mart ("Shoppers") medical cannabis verification pilot program (the "Pilot Program"). The blockchain-secured Pilot Program is specifically designed to increase transparency, interoperability and product identification within the medical cannabis industry.

    • Deloitte and TruTrace Technologies Inc. form strategic alliance to improve cannabis quality control and safety for retailers and consumers
      CNW Group

      Deloitte and TruTrace Technologies Inc. form strategic alliance to improve cannabis quality control and safety for retailers and consumers

      OTCQB: TTTSF) ("TruTrace") have announced a strategic alliance to deliver blockchain product-traceability solutions to the cannabis industry. The alliance will improve clients' ability to build trusted brands, ensure medical and recreational distributors and retailers receive accurate shipments, and provide consumers with confidence they are buying verified products from credible sources. Cannabis legalization in Canada has resulted in exciting opportunities and innovations for industry stakeholders, as well as complex business challenges.

    • GlobeNewswire

      Segra International to be a Lead Genetics Partner in Shoppers Drug Mart and TruTrace Technologies Pilot Traceability Program for Medical Cannabis

      OTC: TTTSF) ("TruTrace" or the "Company"), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, and Segra International Corp. (“Segra”), an agriculture technology company, today announced that the two companies have entered into a letter of intent ("LOI") to establish Segra as a primary genetics verification provider for TruTrace. Pursuant to the LOI, Segra will be a lead genetics partner in the Shoppers Drug Mart (“Shoppers”) and TruTrace Technologies medical cannabis verification pilot program recently announced at the World Cannabis Congress (the “Pilot Program”).

    • TruTrace Technologies Announces Fiscal 2019 Financial and Operating Results
      CNW Group

      TruTrace Technologies Announces Fiscal 2019 Financial and Operating Results

      OTCQB: TTTSF) ("TruTrace" or the "Company"), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today announced its financial and operating results for the year ended April 30 , 2019.  The Company operated as BLOCKStrain Technology Corp. until April 2019 when it changed its name to TruTrace Technologies Inc. All figures are stated in Canadian dollars. "We are very proud of what our team has accomplished in our first full year of operations, advancing from a start-up to the developer of a comprehensive platform for tracking cannabis from genome to sale," said TruTrace Technologies CEO Robert Galarza . "Our momentum has continued into fiscal 2020, highlighted by the recent commencement of the Shoppers Drug Mart medical cannabis traceability pilot program.

    • TruTrace Technologies Closes First Tranche of Private Placement
      CNW Group

      TruTrace Technologies Closes First Tranche of Private Placement

      OTCQB: TTTSF) ("TruTrace" or the "Company") today announced that it has closed a first tranche (the "First Tranche") of a non-brokered private placement financing (the "Financing").  The First Tranche consisted of 2,040,000 units (each, a "Unit") of the Company at a price of $0.25 per Unit for gross proceeds of $510,000 . Each Unit consists of one common share and one non-transferable common share purchase warrant (each, a "Warrant"). Each Warrant entitles the holder to purchase one additional common share at a price of $0.30 per common share for a period of three (3) years from the closing of the Financing. The Company expects to close a second tranche of the Financing in a timely manner.

    • TruTrace Technologies and Anandia to Collaborate on Analytical and Genetic Testing for Cannabis
      CNW Group

      TruTrace Technologies and Anandia to Collaborate on Analytical and Genetic Testing for Cannabis

      OTCQB: TTTSF) ("TruTrace"), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today announced that it has signed a letter of intent ("LOI") to establish a strategic working relationship with Anandia Laboratories Inc. ("Anandia"). The two companies intend to collaborate on an integrated testing solution in relation to TruTrace's development of a blockchain-secured traceability ecosystem for the cannabis industry. Anandia is considered an industry leader in science, genetics, and independent cannabis product testing.

    • Shoppers Drug Mart and TruTrace Technologies Successfully Complete Phase 1 of the Medical Cannabis Verification Pilot Program
      CNW Group

      Shoppers Drug Mart and TruTrace Technologies Successfully Complete Phase 1 of the Medical Cannabis Verification Pilot Program

      OTCQB: TTTSF) ("TruTrace" or the "Company"), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today announced the successful completion of Phase 1 of the blockchain-secured pilot program (the "Pilot Program") with Shoppers Drug Mart ("Shoppers"). The Pilot Program is specifically designed to increase transparency, interoperability and product identification within the medical cannabis industry.

    • The Flowr Corporation Joins Shoppers Drug Mart and TruTrace Technologies Pilot Program for Validation of Medical Cannabis
      CNW Group

      The Flowr Corporation Joins Shoppers Drug Mart and TruTrace Technologies Pilot Program for Validation of Medical Cannabis

      OTCQB: TTTSF) ("TruTrace" or the "Company") today announced that Flowr joined the Shoppers Drug Mart ("Shoppers") medical cannabis verification pilot program (the "Pilot Program"), which was announced last month at the World Cannabis Congress. The Pilot Program is intended to increase transparency, interoperability and product identification within the medical cannabis industry.

    • TruTrace Technologies Announces OTCQB Listing
      CNW Group

      TruTrace Technologies Announces OTCQB Listing

      OTCQB: TTTSF) ("TruTrace" or the "Company"), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today announced that its common shares have commenced trading on the OTCQB® Venture Market, under the symbol TTTSF. The Company believes that trading on the OTCQB, along with the DTC eligibility it secured earlier this year, provides additional liquidity and exposure amongst U.S. investors. "As our company continues to execute on its growth strategy, the United States market is becoming increasingly important both in terms of investor interest and strategic opportunities," said TruTrace Technologies CEO Robert Galarza .

    • A&L Canada Laboratories to be lead analytical testing facility in Shoppers Drug Mart and TruTrace Pilot Traceability Program for Medical Cannabis
      CNW Group

      A&L Canada Laboratories to be lead analytical testing facility in Shoppers Drug Mart and TruTrace Pilot Traceability Program for Medical Cannabis

      OTC: TTTSF) ("TruTrace" or the "Company"), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today announced that A&L will be one of the inaugural testing facilities in the Shoppers Drug Mart ("Shoppers") and TruTrace Technologies medical cannabis verification pilot program (the "Pilot Program").